NCCMH E-bulletin - Vol 10 Iss 3 (Sept - Oct 2011)

The NCCMH's e-bulletin contains Internet links to the latest mental health news, including clinical news, health and social care guidance, publications and policy. Read the latest news below or use the news archive to find news items from the past. Issues of our e-bulletin are published every two months.

To get the e-bulletin delivered by E-mail, click here. To unsubscribe, please send a message to admin@nccmh.org.uk with the subject heading 'Unsubscribe NCCMH E-bulletin'.

September - October 2011.
Alzheimer's Disease International World Alzheimer’s Report published – report
Audit Commission Health Update
British Medical Association BMA promotes patient involvement in commissioning BMA publishes results of major survey of GP opinion – survey BMA sets out changes needed to the Health and Social Care Bill – briefing paper BMA urges doctors to be community leaders as well as clinicians – report BMA welcomes alcohol pricing pledge Concern over work-related depression Consultants' concern over section 12 approval Ministers propose uniform strategy for mental health New public health body must be independent, agrees BMA Praise for strong medical research in UK Psychiatrists challenge bid to drop depression from QOF Psychiatrists urge more aid for medics at risk of suicide Social determinants of health - what can doctors do? - report
Canadian Agency for Drugs and Technologies in Health (CADTH) CADTH Rapid Response Report: Clinical evidence for Suboxone® (buprenorphine/naloxone) for short-term detoxification – report CADTH Rapid Response Report: Evidence on the safety of combination benzodiazepine-opioid use - report CADTH Rapid Response Report: Treatment programs for prescription drug abuse – report CADTH summary: Guidelines and recommendations for ADHD in children and adolescents – report CADTH systematic review and meta-analysis: Pharmacological and non-pharmacological therapies for adults with ADHD
Care Quality Commission Care Quality Commission launches consultation on fees CQC calls for action to improve care for older people – report CQC reports on the picture of health and social care in England – report Getting ready for HealthWatch England Our response to the Health Select Committee report
Carers UK Care & Support Alliance calls for social care reform
Centre for Mental Health Centre for Mental Health responds to Government plans for Personality Disorder Services in Prisons Centre for Mental Health welcome commitment to challenge stigma from Department of Health and Comic Relief Centre welcomes Government investment in psychological therapies for children and young people with mental health problems Commentary on Barclays Wealth/New Philanthropy Capital report on ‘Early interventions: an economic approach to charitable giving’ – report Mental health care and the criminal justice system – briefing paper New report from The Social Care Institute for Excellence (SCIE) and Centre for Mental Health examining the barriers to working in social care for people with mental health problems – report
The Centre for Social Justice Completing the revolution – transforming mental health and tackling poverty – report Poorest with mental health problems failed by ‘care’ in the community, warns major new report – report
Cochrane Collaboration New systematic reviews: Pharmacologic treatment for memory disorder in multiple sclerosis Updated reviews: Acupuncture for vascular dementia Decision aids for people facing health treatment or screening decisions Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence Strategies to improve recruitment to randomised controlled trials New protocols: Crisis interventions for people with borderline personality disorder Cultural competence education for health professionals Haloperidol (rapid tranquilisation) for psychosis induced aggression or agitation Interventions to improve the use of systematic reviews for clinical and commissioning decision-making Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia Pharmacological interventions for people with histrionic personality disorder Pharmacological interventions for people with narcissistic personality disorder Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders Psychological, social and welfare interventions for psychological health and well-being of torture survivors Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia New titles: Empirical evidence for the impact of incomplete follow-up in RCTs and suggested statistical models for meta-analysis (Methodology Review Group) Flupenthixol versus placebo for schizophrenia (Schizophrenia Group) Means restriction for the prevention of suicide (Depression, Anxiety and Neurosis Group) Psychosocial aftercare for those bereaved by suicide (Protocol) (Depression, Anxiety and Neurosis Group) Therapist supported e-health interventions for treatment of alcohol related problems (Drugs and Alcohol Group)
Department of health (DoH) £20 million to knock down mental health stigma Abortion statistics information updated Chief Nursing Officer introduces mental health nursing framework Children and teenagers to benefit from successful adult mental health therapy Commissioning of substance misuse services from April 2013 – letter Delivery of expert patients programme Draft mental health PbR guidance for 2012-13 and update on other PbR issues – letter and draft guidance GP contract agreement allows patients more choice Health and Social Care Bill revised Impact Assessment published – publication Healthy lives, healthy people: update and way forward, easy read version published – publication Improved mental health therapies for children Improving dementia care Launch of the Clinical Practice Research Datalink Long term health conditions 2011: research study New Health Research Authority comes a step closer NHS support for social care: provision of support for memory services – letter Offender personality disorder – consultation response – response to consultation Online tools aid patient health decisions Patients to have a greater say and choice over their care Public health experts’ concern over Health Bill Raising dementia awareness Reports published on investment levels in mental health services – reports The public wants more choice of NHS care Top ten frequently asked questions on the Health and Social Care Bill Transparency in the NHS: Good for patients, good for doctors
European Medicines Agency (EMEA) CHMP revised EPARs started on: Abilify, Aripiprazole, Revision: 22, Authorised Ariclaim, Duloxetine, Revision: 16, Authorised Nimvastid, Rivastigmine, Revision: 2, Authorised Olanzapine Mylan, Olanzapine, Revision: 5, Authorised Olanzapine Teva, Olanzapine, Revision: 8, Authorised Rivastigmine Teva, Rivastigmine, Revision: 3, Authorised Xeplion, Paliperidone, Revision: 1, Authorised Zalasta, Olanzapine, Revision: 8, Authorised Opinion/decision: Paediatric Investigation Plan (PIP): -, Loxapine Paediatric Investigation Plan (PIP): Olanzapine Apotex, Olanzapine Paediatric Investigation Plan (PIP): Sycrest, Asenapine (maleate) Reports/guidance: Concept paper on the need for revision of the appendix to the Note for Guidance on the clinical investigation of medicinal products in the treatment of schizophrenia – methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia – scientific guideline Guideline on clinical investigation of medicinal products in the treatment of depression – scientific guideline Qualification opinion of low hippocampal volume (atrophy) by MRI for use in regulatory clinical trials - in pre-dementia stage of Alzheimer’s disease – regulatory and procedural guideline
Food and Drug Administration (FDA) Approvals: Alprazolam (anda # 078469) Anchen Pharms Clobazam (nda # 202067) Lundbeck Inc Dextroamphetamine sulphate (anda # 090533) Mikart Eszoplicone (anda # 091124) Lupin Ltd Fluoxetine (nda # 202133) Edgemont Pharms Galantamine hydrobromide (anda # 077781) Apotex Inc Haloperidol lactate (anda # 091637) Sagent Pharms Haloperidol lactate (anda # 200742) Sagent Pharms Lisdexamfetamine dimesylate (nda # 021977) Shire Development Loxapine succinate (anda # 090695) Lannett Holdings Inc Memantine hydrochloride (anda # 090052) Teva Pharms Olanzapine (anda # 076000) Teva Pharms Olanzapine (anda # 076133) Dr Reddys Labs Ltd Olanzapine (anda # 076534) Dr Reddys Labs Ltd Olanzapine (anda # 078109) Par Pharm Olanzapine (anda # 091265) Apotex Inc Olanzapine (anda # 091415) Torrent Pharms LLC Olanzapine (anda # 201588) Innopharma LLC Tentative Approvals: Memantine hydrochloride (anda # 200155) Torrent Pharms Quetiapine fumarate (anda # 090120) Roxane Quetiapine fumerate (anda # 090749) Roxane Drug Safety Communication: FDA approves first generic olanzapine to treat schizophrenia, bipolar disorder
Joseph Rowntree Foundation (JRF) A 'four nations' perspective on rights, responsibilities, risk and regulation in adult social care – scoping paper Does income inequality cause health and social problems? – report
Improving Access to Psychological Therapies (IAPT) Enhancing recovery rates in IAPT services: lessons from year one data - report The Children and Young People's IAPT Project is delighted to announce the Phase One Learning Collaboratives Working with under 18 year olds: Guidance for Commissioners, IAPT service providers and those working in IAPT services
Kings Fund Environments of care for people with dementia Integrated care summary: What is it? Does it work? What does it mean for the NHS? - publication Social care and clinical commissioning for people with long-term conditions – briefing The King's Fund responds to The Health Select Committee's Report on Public Health Think tanks work together to support integrated care for patients
Medical Research Council (MRC) ‘Sensitivity gene’ predicts whether anxious children will benefit from CBT
Medicines and Healthcare products Regulatory Agency (MHRA) Antipsychotics: use during third trimester of pregnancy and extrapyramidal effects or withdrawal symptoms in newborns Letter for healthcare professionals on the safety of medicines: Associaton of Cipramil (citalopram hydrobromide) with dose-dependent QT interval prolongation Reboxetine: A review of the benefits and risks
Mental Health Foundation (MHF) An Evidence Review of the Impact of Participatory Arts on Older People – report Brighter Futures: Supporting mental health in later life – report New booklet to help people better manage their mental health in later life – booklet Our response to CQC report on the standards of care that older people receive in hospital Our response to NHS Improving Access to Psychological Therapies report Our response to the NHS Information Centre new data on the use of the Mental Health Act Personal Budgets For People With Dementia – report Response to Government's £32m investment in children and young people's mental health We support calls for earlier intervention for mental disorders
MIND It’s time to act on mental health at work – report Mental health defenders - because nobody wins when mental health loses – booklet Mind fights back against benefits stigma
National electronic Library for Medicines (NeLM) Adjunctive antipsychotics for major depression Analysis investigates risks of suicidal behavior and depression with smoking cessation treatments Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication Case control study: Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias Case control study: Psychotropic medications and the risk of sudden cardiac death during an acute coronary event Cholesterol level and statin use in Alzheimer disease: review of epidemiological and preclinical studies Clinical practice article on depression during pregnancy Cochrane review: Acupuncture for autism spectrum disorders (ASD) Cognitive behaviour therapy augmentation of pharmacotherapy in paediatric obsessive-compulsive disorder – results of the POTS II study Cohort study: Study finds that higher intake of coffee may be associated with a lower risk of depression in women Cohort study: Zolpidem associated with higher risk of fractures compared to lorazepam and alprazolam, and similar risk to diazepam Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population Discussion: Alcohol and drug problems in older people Elevated depressive symptoms and antidepressant use in postmenopausal women increases risk of diabetes? Generic olanzapine (Actavis) launched in the UK Horizon scanning: Preliminary results for lisdexamfetamine dimesylate (LDX) for the treatment of symptoms of ADHD Lancet Series on mental health Meta-analysis: Efficacy and comparative effectiveness of atypical antipsychotics for off-label uses Monitoring unwanted effects of antipsychotics Multi-disciplinary perceptions of patient group directions as a replacement for the pro re nata prescribing of antipsychotic medications in acute mental health settings New national IM monograph on Midazolam Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics Observational study: Use of anti-dementia drugs may delay but not prevent care home placement RCT: Cognitive behaviour therapy augmentation of pharmacotherapy in paediatric obsessive-compulsive disorder – results of the POTS II study Review: Depression in older adults Review: Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia Study finds that higher intake of coffee may be associated with a lower risk of depression in women Systematic review and meta-analysis of published placebo controlled trials of citalopram for major depressive disorder in adults Systematic review: Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders Updated national IV monograph on Buprenorphine What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association
National Institute for Health and Clinical Excellence (NICE) Advice from NICE aims to improve commissioning of services for people with common mental health disorders Antisocial personality disorder: review proposal consultation Borderline personality disorder (BPD): review proposal consultation Changes to the way you receive NICE guidance Consultation on NICE's proposals for changes to the process and methods for public health guidance development – open for consultation [closes 9 January 2012] Autism in children and young people - guidance NICE QOF indicators taken up Number of off-licences linked to harmful drinking among young people Post-traumatic stress disorder (PTSD): review proposal consultation Set up "autism teams" to improve services for under-18s, says NICE
National Institute for Health Research (NIHR) Annual report 2011/12 published
National Prescribing Centre (NPC) Letters to patients may help to reduce benzodiazepine use
National Treatment Agency for Substance Misuse Fall in opiate and crack use in England: independent research published today Latest drugs data show more on road to recovery – report New feedback function available for service users to report difficulties in accessing residential rehabilitation
NHS Choices Alzheimer’s, yeasts and other animals Birthweight link to autism not clear Call for action on 'legal high' drugs Can vitamin B prevent Alzheimer's? Mice fed yoghurt 'less depressed' Postnatal depression 'often unreported' Scale of mental health problems examined Student mental health issues raised
NHS Confederation A positive partnership - the independent sector and the NHS – briefing Commission on dignity in care gets underway Key facts and trends in mental health – factsheet NHS Confederation response to CQC State of Care report Patient and public engagement in the new commissioning system – discussion paper Personal health budgets: countdown to roll-out – briefing The influence of health services research on the NHS – briefing
NHS Information Centre Abuse of vulnerable adults in England, 2010-11: provisional, experimental statistics - report Community Care Statistics: Grant Funded Services for Adults, England - 2010-11 - report Establishment of Memory Services - results of a survey of PCTs, final figures 2011 - report Guardianship under the Mental Health Act 1983 - England 2011 - report Improving Access to Psychological Therapies Key Performance Indicators (IAPT KPIs) Q1 Apr 2011 - Jun 2011 Inpatients formally detained in hospitals under the Mental Health Act 1983 and patients subject to supervised community treatment, Annual figures, England 2010/11 - bulletin Personal Social Services Adult Social Care Survey, England - Provisional 2010-11 – survey Prescribing compliance: a review of the proportion of prescriptions dispensed Social Care and Mental Health Indicators from the National Indicator Set: 2010-11 provisional release - report
Office for National Statistics Scotland: Prescribing Statistics - Medicines used in Mental Health - Sept 2011 Release Wales: Admission of Patients to Mental Health Facilities, 2010-11 Assessments and Social Services for Adults, 2010-11 Substance Misuse in Wales - 2010-11
PLoS One Suicidal Behavior and Depression in Smoking Cessation Treatments – research article
Prodigy Dementia – guidance (updated to include a summary of key recommendations from the World Alzheimer Report 2011)
Rethink Increase in mortality gap for people with serious mental illness is unacceptable says mental health charity
Royal College of General Practitioners (RCGP) Care not cost, says RCGP leader Care Planning: Improving the Lives of People with Long Term Conditions – standards document GPs go into action for carers - guidance New online course for GPs to improve care for thousands of veterans New RCGP Guidance to help GPs with ethics of commissioning RCGP reaction to second reading of Health and Social Care Bill Results of latest RCGP survey on Health and Social Care Bill Supporting carers - an action guide for general practitioners and their teams
Royal College of Physicians (RCP) Commissioning groups need local knowledge, says RCP New toolkit to support high quality care for acutely ill patients Patients need guarantee of national standards for doctors training RCP calls for public health professionals to have strong links with the NHS RCP comment on Commission on Generalism report: Guiding Patients through Complexity: Modern Medical Generalism RCP comments on the frequency of alcohol consumption
Royal College of Psychiatrists (RCPsych) More mental health support needed for students in higher education – report RCPsych publishes results of Health and Social Care Bill survey – survey
Royal Pharmaceutical Society of Great Britain (RPSGB) RPS raises concerns over the Health and Social Bill – briefing
Scottish Medicines Consortium (SMC) SMC does not recommend quetiapine (Seroquel XL®) as add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy
Social Care Institute for Excellence (SCIE) Improving access to social care for adults with autism - guide Mental health, employment and the social care workforce - report Parental substance misuse - new elearning materials for social workers